

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.40521437 |
| 2 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.07297899 |
| 3 | presynaptic membrane organization (GO:0097090) | 4.87777675 |
| 4 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.71726742 |
| 5 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.69138969 |
| 6 | glutamate secretion (GO:0014047) | 4.58715876 |
| 7 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.48332515 |
| 8 | transferrin transport (GO:0033572) | 4.46133470 |
| 9 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.35673482 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 4.27783280 |
| 11 | synaptic vesicle endocytosis (GO:0048488) | 4.26430711 |
| 12 | response to peptidoglycan (GO:0032494) | 4.23993154 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.19407470 |
| 14 | presynaptic membrane assembly (GO:0097105) | 4.18829286 |
| 15 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.18755146 |
| 16 | ATP hydrolysis coupled proton transport (GO:0015991) | 4.18755146 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 4.18307563 |
| 18 | ferric iron transport (GO:0015682) | 4.17546078 |
| 19 | trivalent inorganic cation transport (GO:0072512) | 4.17546078 |
| 20 | neuronal action potential propagation (GO:0019227) | 4.17443929 |
| 21 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.17007052 |
| 22 | vocalization behavior (GO:0071625) | 4.16585422 |
| 23 | glycosphingolipid catabolic process (GO:0046479) | 4.01521351 |
| 24 | negative regulation of interleukin-12 production (GO:0032695) | 3.99620592 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 3.96659005 |
| 26 | regulation of vitamin metabolic process (GO:0030656) | 3.96394067 |
| 27 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.90425584 |
| 28 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.89893574 |
| 29 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.88198219 |
| 30 | long-term synaptic potentiation (GO:0060291) | 3.84623339 |
| 31 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.83869133 |
| 32 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.83649558 |
| 33 | startle response (GO:0001964) | 3.75460976 |
| 34 | phagosome maturation (GO:0090382) | 3.73391710 |
| 35 | synaptic vesicle maturation (GO:0016188) | 3.73098620 |
| 36 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.72990758 |
| 37 | neuron-neuron synaptic transmission (GO:0007270) | 3.70630059 |
| 38 | protein localization to synapse (GO:0035418) | 3.70127442 |
| 39 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.69315873 |
| 40 | neurotransmitter secretion (GO:0007269) | 3.66370399 |
| 41 | oligosaccharide catabolic process (GO:0009313) | 3.64146103 |
| 42 | regulation of chronic inflammatory response (GO:0002676) | 3.61611242 |
| 43 | regulation of fever generation (GO:0031620) | 3.61143014 |
| 44 | glycolipid catabolic process (GO:0019377) | 3.59662670 |
| 45 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.54898221 |
| 46 | positive regulation of heat generation (GO:0031652) | 3.53095185 |
| 47 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.50106022 |
| 48 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.48814164 |
| 49 | synaptic transmission, glutamatergic (GO:0035249) | 3.48617415 |
| 50 | regulation of mononuclear cell migration (GO:0071675) | 3.47739857 |
| 51 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.44858214 |
| 52 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.40926870 |
| 53 | ceramide catabolic process (GO:0046514) | 3.34114451 |
| 54 | negative regulation of dendrite development (GO:2000171) | 3.32556285 |
| 55 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.30463041 |
| 56 | regulation of synaptic plasticity (GO:0048167) | 3.30277615 |
| 57 | postsynaptic membrane organization (GO:0001941) | 3.27903199 |
| 58 | regulation of podosome assembly (GO:0071801) | 3.27607475 |
| 59 | locomotory exploration behavior (GO:0035641) | 3.26280242 |
| 60 | macrophage activation involved in immune response (GO:0002281) | 3.24384053 |
| 61 | glutamate receptor signaling pathway (GO:0007215) | 3.23331149 |
| 62 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.21061175 |
| 63 | cellular response to arsenic-containing substance (GO:0071243) | 3.19453975 |
| 64 | establishment of synaptic vesicle localization (GO:0097480) | 3.19428562 |
| 65 | synaptic vesicle transport (GO:0048489) | 3.19428562 |
| 66 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.18672772 |
| 67 | germinal center formation (GO:0002467) | 3.16119166 |
| 68 | negative regulation of neurotransmitter transport (GO:0051589) | 3.15887179 |
| 69 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.14313228 |
| 70 | regulation of chemokine biosynthetic process (GO:0045073) | 3.13929583 |
| 71 | neuron recognition (GO:0008038) | 3.13251902 |
| 72 | axonal fasciculation (GO:0007413) | 3.13007436 |
| 73 | protein localization to endosome (GO:0036010) | 3.12931121 |
| 74 | inositol phosphate catabolic process (GO:0071545) | 3.12495948 |
| 75 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.11775971 |
| 76 | positive regulation of synapse maturation (GO:0090129) | 3.11495939 |
| 77 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.09466105 |
| 78 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.07224593 |
| 79 | cerebellar granule cell differentiation (GO:0021707) | 3.06973665 |
| 80 | negative regulation of interleukin-17 production (GO:0032700) | 3.02694386 |
| 81 | regulation of early endosome to late endosome transport (GO:2000641) | 3.01650019 |
| 82 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.01147514 |
| 83 | response to thyroid hormone (GO:0097066) | 2.99774624 |
| 84 | sphingosine metabolic process (GO:0006670) | 2.99709866 |
| 85 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.99187706 |
| 86 | regulation of neurotransmitter secretion (GO:0046928) | 2.96613918 |
| 87 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.95503790 |
| 88 | response to histamine (GO:0034776) | 2.95460498 |
| 89 | membrane lipid catabolic process (GO:0046466) | 2.95419595 |
| 90 | ER overload response (GO:0006983) | 2.94989337 |
| 91 | exploration behavior (GO:0035640) | 2.93556822 |
| 92 | positive regulation of type 2 immune response (GO:0002830) | 2.93179636 |
| 93 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.92225961 |
| 94 | regulation of synapse structural plasticity (GO:0051823) | 2.90925451 |
| 95 | regulation of postsynaptic membrane potential (GO:0060078) | 2.90174558 |
| 96 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.87068382 |
| 97 | myeloid dendritic cell differentiation (GO:0043011) | 2.87035533 |
| 98 | neurotransmitter transport (GO:0006836) | 2.86028737 |
| 99 | proline transport (GO:0015824) | 2.84765839 |
| 100 | T-helper 1 type immune response (GO:0042088) | 2.83301799 |
| 101 | sphingolipid catabolic process (GO:0030149) | 2.82911401 |
| 102 | cellular response to lipopolysaccharide (GO:0071222) | 2.82328579 |
| 103 | cullin deneddylation (GO:0010388) | 2.82088202 |
| 104 | calcium ion-dependent exocytosis (GO:0017156) | 2.81820766 |
| 105 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.81729033 |
| 106 | granulocyte activation (GO:0036230) | 2.80906925 |
| 107 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.80246290 |
| 108 | learning (GO:0007612) | 2.80181374 |
| 109 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.79223496 |
| 110 | gamma-aminobutyric acid transport (GO:0015812) | 2.78571380 |
| 111 | positive regulation of membrane potential (GO:0045838) | 2.77881625 |
| 112 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.77758848 |
| 113 | positive regulation of interleukin-6 production (GO:0032755) | 2.77350139 |
| 114 | regulation of neurotransmitter transport (GO:0051588) | 2.76115233 |
| 115 | establishment of vesicle localization (GO:0051650) | 2.74975256 |
| 116 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.73566336 |
| 117 | regulation of heat generation (GO:0031650) | 2.71620683 |
| 118 | cellular response to molecule of bacterial origin (GO:0071219) | 2.71236936 |
| 119 | serotonin receptor signaling pathway (GO:0007210) | 2.68813879 |
| 120 | response to manganese ion (GO:0010042) | 2.67945808 |
| 121 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.67711590 |
| 122 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.67492023 |
| 123 | neuromuscular process controlling posture (GO:0050884) | 2.66774823 |
| 124 | negative regulation of lipid storage (GO:0010888) | 2.65857352 |
| 125 | synaptic transmission (GO:0007268) | 2.65664137 |
| 126 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.65561733 |
| 127 | transmission of nerve impulse (GO:0019226) | 2.65071566 |
| 128 | adenosine receptor signaling pathway (GO:0001973) | 2.64709679 |
| 129 | regulation of neurotransmitter levels (GO:0001505) | 2.64524533 |
| 130 | diol metabolic process (GO:0034311) | 2.64366081 |
| 131 | regulation of synaptic transmission (GO:0050804) | 2.63813517 |
| 132 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.63618375 |
| 133 | regulation of synapse maturation (GO:0090128) | 2.63450181 |
| 134 | long term synaptic depression (GO:0060292) | 2.63330532 |
| 135 | regulation of vesicle fusion (GO:0031338) | 2.62845932 |
| 136 | behavioral response to cocaine (GO:0048148) | 2.62834209 |
| 137 | iron ion transport (GO:0006826) | 2.62563349 |
| 138 | neuromuscular process (GO:0050905) | 2.62284393 |
| 139 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.62204631 |
| 140 | mechanosensory behavior (GO:0007638) | 2.62139029 |
| 141 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.61210080 |
| 142 | positive regulation of synaptic transmission (GO:0050806) | 2.60858378 |
| 143 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.60822657 |
| 144 | response to nerve growth factor (GO:1990089) | 2.60822657 |
| 145 | negative regulation of growth of symbiont in host (GO:0044130) | 2.60398877 |
| 146 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.60398877 |
| 147 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.60398877 |
| 148 | regulation of growth of symbiont in host (GO:0044126) | 2.60398877 |
| 149 | nerve growth factor signaling pathway (GO:0038180) | 2.60153169 |
| 150 | positive regulation of leukocyte degranulation (GO:0043302) | 2.60069149 |
| 151 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.59959673 |
| 152 | dendritic cell differentiation (GO:0097028) | 2.59612540 |
| 153 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.57629129 |
| 154 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.57538859 |
| 155 | regulation of glutamate secretion (GO:0014048) | 2.56362594 |
| 156 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.55946757 |
| 157 | detection of calcium ion (GO:0005513) | 2.55186375 |
| 158 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.54332122 |
| 159 | positive regulation of synapse assembly (GO:0051965) | 2.54189946 |
| 160 | female mating behavior (GO:0060180) | 2.53943525 |
| 161 | positive regulation of mitochondrial fission (GO:0090141) | 2.53324654 |
| 162 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.53129246 |
| 163 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.51990705 |
| 164 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.51962446 |
| 165 | adult walking behavior (GO:0007628) | 2.51625663 |
| 166 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.51282258 |
| 167 | neuronal ion channel clustering (GO:0045161) | 2.50798007 |
| 168 | regulation of interferon-alpha production (GO:0032647) | 2.50648865 |
| 169 | protein deneddylation (GO:0000338) | 2.49738589 |
| 170 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.49575288 |
| 171 | regulation of immunoglobulin secretion (GO:0051023) | 2.48154330 |
| 172 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.47308488 |
| 173 | regulation of type 2 immune response (GO:0002828) | 2.46223639 |
| 174 | positive regulation of natural killer cell activation (GO:0032816) | 2.45697617 |
| 175 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.43553125 |
| 176 | response to protozoan (GO:0001562) | 2.43300198 |
| 177 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.39522045 |
| 178 | regulation of interleukin-12 production (GO:0032655) | 2.39369298 |
| 179 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.39346563 |
| 180 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.38749530 |
| 181 | defense response to protozoan (GO:0042832) | 2.36869882 |
| 182 | regulation of interleukin-17 production (GO:0032660) | 2.36814989 |
| 183 | macrophage activation (GO:0042116) | 2.36670038 |
| 184 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.36019383 |
| 185 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.35855650 |
| 186 | eosinophil chemotaxis (GO:0048245) | 2.34622371 |
| 187 | cellular response to biotic stimulus (GO:0071216) | 2.34176141 |
| 188 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.33696944 |
| 189 | myeloid dendritic cell activation (GO:0001773) | 2.32600917 |
| 190 | myeloid cell activation involved in immune response (GO:0002275) | 2.32519011 |
| 191 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.32203460 |
| 192 | monocyte chemotaxis (GO:0002548) | 2.30768413 |
| 193 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.30743912 |
| 194 | NIK/NF-kappaB signaling (GO:0038061) | 2.29893646 |
| 195 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.29145907 |
| 196 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.28492563 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.82089646 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.94811598 |
| 3 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.86160179 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.79693096 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.69497642 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.61175588 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.53186685 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.49984136 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.48305327 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.41360913 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.36040996 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.00361043 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.92398503 |
| 14 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.89009014 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.84834414 |
| 16 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.76474388 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.72217440 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.65659235 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.62704497 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.52648902 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.52038134 |
| 22 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.51692143 |
| 23 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.48586735 |
| 24 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.48309674 |
| 25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.41427897 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.33310115 |
| 27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.25339979 |
| 28 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.25181736 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.22950231 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.21492774 |
| 31 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.17735559 |
| 32 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.16886458 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.15705872 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.12576275 |
| 35 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.10247139 |
| 36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.07712551 |
| 37 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.06270708 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 2.03594433 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 2.03217046 |
| 40 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.02607076 |
| 41 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.02214214 |
| 42 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.99575347 |
| 43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.98159003 |
| 44 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.97323881 |
| 45 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.96618049 |
| 46 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.95868264 |
| 47 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.95868264 |
| 48 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.95218469 |
| 49 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.92187001 |
| 50 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.91868779 |
| 51 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.91629999 |
| 52 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.91618158 |
| 53 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.89975898 |
| 54 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.88333599 |
| 55 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.86922288 |
| 56 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.85871675 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.81465992 |
| 58 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.79670440 |
| 59 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.78075327 |
| 60 | FUS_26573619_Chip-Seq_HEK293_Human | 1.72482582 |
| 61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.70220922 |
| 62 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.69130506 |
| 63 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.69102500 |
| 64 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.68899818 |
| 65 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.66122676 |
| 66 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.64979394 |
| 67 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.64925335 |
| 68 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.59036557 |
| 69 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.57463598 |
| 70 | AR_25329375_ChIP-Seq_VCAP_Human | 1.54719774 |
| 71 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.53787429 |
| 72 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.52781033 |
| 73 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.52554732 |
| 74 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52165518 |
| 75 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51812792 |
| 76 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.50870734 |
| 77 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.49923584 |
| 78 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.45544477 |
| 79 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.44746823 |
| 80 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.44735388 |
| 81 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.44266806 |
| 82 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43866417 |
| 83 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.43750113 |
| 84 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43202485 |
| 85 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.41051465 |
| 86 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.40826040 |
| 87 | VDR_22108803_ChIP-Seq_LS180_Human | 1.40587733 |
| 88 | STAT3_23295773_ChIP-Seq_U87_Human | 1.38805394 |
| 89 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.37828937 |
| 90 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37222911 |
| 91 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.35325427 |
| 92 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.34969741 |
| 93 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.34394328 |
| 94 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.34394328 |
| 95 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.33503239 |
| 96 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.33411323 |
| 97 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33182317 |
| 98 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31997010 |
| 99 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.31918865 |
| 100 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.31626609 |
| 101 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29797684 |
| 102 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.29587885 |
| 103 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29516233 |
| 104 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.29119870 |
| 105 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.27797391 |
| 106 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.27636699 |
| 107 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26802647 |
| 108 | GATA1_19941826_ChIP-Seq_K562_Human | 1.26133688 |
| 109 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25784146 |
| 110 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25291358 |
| 111 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24761714 |
| 112 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.23969720 |
| 113 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23760405 |
| 114 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23694032 |
| 115 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.23446708 |
| 116 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23167500 |
| 117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.20617910 |
| 118 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.20617910 |
| 119 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.20354520 |
| 120 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.19874071 |
| 121 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18619278 |
| 122 | EWS_26573619_Chip-Seq_HEK293_Human | 1.18585957 |
| 123 | JUN_21703547_ChIP-Seq_K562_Human | 1.18249371 |
| 124 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.17129871 |
| 125 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.16704814 |
| 126 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16473763 |
| 127 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.16107090 |
| 128 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16043950 |
| 129 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15685697 |
| 130 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.15319927 |
| 131 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.15272336 |
| 132 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.14792383 |
| 133 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.13395468 |
| 134 | RXR_22108803_ChIP-Seq_LS180_Human | 1.13010848 |
| 135 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12671533 |
| 136 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.10576003 |
| 137 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.10454311 |
| 138 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09368727 |
| 139 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08924376 |
| 140 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.08884164 |
| 141 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.08839611 |
| 142 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.08822948 |
| 143 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08087359 |
| 144 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.07818728 |
| 145 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07803300 |
| 146 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.07258182 |
| 147 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07213906 |
| 148 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.06070673 |
| 149 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05720325 |
| 150 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.05066780 |
| 151 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04660294 |
| 152 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.04531004 |
| 153 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.03058308 |
| 154 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02919254 |
| 155 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00988991 |
| 156 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00862680 |
| 157 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.00323670 |
| 158 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99186474 |
| 159 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.99065767 |
| 160 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.97770236 |
| 161 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97533483 |
| 162 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97238180 |
| 163 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97020416 |
| 164 | MYB_26560356_Chip-Seq_TH2_Human | 0.96986426 |
| 165 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.96853412 |
| 166 | * AR_19668381_ChIP-Seq_PC3_Human | 0.95968197 |
| 167 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.95860547 |
| 168 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.95335672 |
| 169 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94826299 |
| 170 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.94108259 |
| 171 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.93967758 |
| 172 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.93411173 |
| 173 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91605032 |
| 174 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89489954 |
| 175 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.87041986 |
| 176 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.84849518 |
| 177 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84799942 |
| 178 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83895849 |
| 179 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.83407634 |
| 180 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81933312 |
| 181 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80767893 |
| 182 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.80439355 |
| 183 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.79955459 |
| 184 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79337220 |
| 185 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77960876 |
| 186 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.77930223 |
| 187 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.77765285 |
| 188 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.77652280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.87332586 |
| 2 | MP0003303_peritoneal_inflammation | 4.80020083 |
| 3 | MP0003880_abnormal_central_pattern | 4.41179825 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.54226500 |
| 5 | MP0009046_muscle_twitch | 3.40928922 |
| 6 | MP0006082_CNS_inflammation | 3.36118076 |
| 7 | MP0002064_seizures | 3.22014250 |
| 8 | MP0004270_analgesia | 3.18188841 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.17655471 |
| 10 | MP0009745_abnormal_behavioral_response | 3.17482775 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.98771144 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.84641530 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.84480950 |
| 14 | MP0004510_myositis | 2.80298920 |
| 15 | MP0002735_abnormal_chemical_nociception | 2.71938478 |
| 16 | MP0002877_abnormal_melanocyte_morpholog | 2.71118324 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.61418110 |
| 18 | MP0002736_abnormal_nociception_after | 2.60911627 |
| 19 | MP0003724_increased_susceptibility_to | 2.60035049 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.54494344 |
| 21 | MP0009785_altered_susceptibility_to | 2.49017988 |
| 22 | MP0005646_abnormal_pituitary_gland | 2.48414860 |
| 23 | MP0002272_abnormal_nervous_system | 2.47720973 |
| 24 | MP0005171_absent_coat_pigmentation | 2.47143594 |
| 25 | MP0009840_abnormal_foam_cell | 2.42460801 |
| 26 | MP0000343_altered_response_to | 2.36265736 |
| 27 | MP0003436_decreased_susceptibility_to | 2.27880858 |
| 28 | MP0001486_abnormal_startle_reflex | 2.24154262 |
| 29 | MP0001501_abnormal_sleep_pattern | 2.22932272 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 2.20827112 |
| 31 | MP0005645_abnormal_hypothalamus_physiol | 2.19796009 |
| 32 | MP0002733_abnormal_thermal_nociception | 2.19068177 |
| 33 | MP0005423_abnormal_somatic_nervous | 2.15184148 |
| 34 | MP0001835_abnormal_antigen_presentation | 2.14965317 |
| 35 | MP0001970_abnormal_pain_threshold | 2.14812616 |
| 36 | MP0005167_abnormal_blood-brain_barrier | 2.09900840 |
| 37 | MP0002139_abnormal_hepatobiliary_system | 2.07060542 |
| 38 | MP0005000_abnormal_immune_tolerance | 2.03260555 |
| 39 | MP0003183_abnormal_peptide_metabolism | 2.01876644 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 2.01524554 |
| 41 | MP0002419_abnormal_innate_immunity | 1.99352008 |
| 42 | MP0001440_abnormal_grooming_behavior | 1.97593470 |
| 43 | MP0002067_abnormal_sensory_capabilities | 1.96520752 |
| 44 | MP0001984_abnormal_olfaction | 1.96053405 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.96017128 |
| 46 | MP0006054_spinal_hemorrhage | 1.94321309 |
| 47 | MP0003122_maternal_imprinting | 1.84989594 |
| 48 | MP0008004_abnormal_stomach_pH | 1.82590866 |
| 49 | MP0009780_abnormal_chondrocyte_physiolo | 1.82395048 |
| 50 | MP0003453_abnormal_keratinocyte_physiol | 1.81566174 |
| 51 | MP0001790_abnormal_immune_system | 1.79262367 |
| 52 | MP0005387_immune_system_phenotype | 1.79262367 |
| 53 | MP0003191_abnormal_cellular_cholesterol | 1.79124796 |
| 54 | MP0003787_abnormal_imprinting | 1.78842623 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 1.78379384 |
| 56 | MP0009764_decreased_sensitivity_to | 1.77091603 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.75599166 |
| 58 | MP0004947_skin_inflammation | 1.74962393 |
| 59 | MP0000778_abnormal_nervous_system | 1.74457894 |
| 60 | MP0005025_abnormal_response_to | 1.67959735 |
| 61 | MP0010386_abnormal_urinary_bladder | 1.67556944 |
| 62 | MP0008569_lethality_at_weaning | 1.62302594 |
| 63 | MP0004811_abnormal_neuron_physiology | 1.61581595 |
| 64 | MP0005386_behavior/neurological_phenoty | 1.60951152 |
| 65 | MP0004924_abnormal_behavior | 1.60951152 |
| 66 | MP0005451_abnormal_body_composition | 1.60690947 |
| 67 | MP0005671_abnormal_response_to | 1.57098118 |
| 68 | MP0005166_decreased_susceptibility_to | 1.55858279 |
| 69 | MP0006276_abnormal_autonomic_nervous | 1.55330496 |
| 70 | MP0003879_abnormal_hair_cell | 1.55072891 |
| 71 | MP0001853_heart_inflammation | 1.53665075 |
| 72 | MP0002184_abnormal_innervation | 1.48839530 |
| 73 | MP0002452_abnormal_antigen_presenting | 1.47188050 |
| 74 | MP0003448_altered_tumor_morphology | 1.46852436 |
| 75 | MP0002723_abnormal_immune_serum | 1.45785933 |
| 76 | MP0001905_abnormal_dopamine_level | 1.45226760 |
| 77 | MP0001529_abnormal_vocalization | 1.44314063 |
| 78 | MP0002557_abnormal_social/conspecific_i | 1.43404478 |
| 79 | MP0000955_abnormal_spinal_cord | 1.42377135 |
| 80 | MP0002909_abnormal_adrenal_gland | 1.41680062 |
| 81 | MP0004142_abnormal_muscle_tone | 1.40186834 |
| 82 | MP0001845_abnormal_inflammatory_respons | 1.39290055 |
| 83 | MP0001533_abnormal_skeleton_physiology | 1.38909162 |
| 84 | MP0002822_catalepsy | 1.38595987 |
| 85 | MP0002066_abnormal_motor_capabilities/c | 1.37948397 |
| 86 | MP0001188_hyperpigmentation | 1.35580673 |
| 87 | MP0001502_abnormal_circadian_rhythm | 1.31840307 |
| 88 | MP0002998_abnormal_bone_remodeling | 1.31639335 |
| 89 | MP0002876_abnormal_thyroid_physiology | 1.29868234 |
| 90 | MP0003633_abnormal_nervous_system | 1.28400174 |
| 91 | MP0008469_abnormal_protein_level | 1.25097662 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 1.23334843 |
| 93 | MP0001545_abnormal_hematopoietic_system | 1.23334843 |
| 94 | MP0005058_abnormal_lysosome_morphology | 1.22466842 |
| 95 | MP0002882_abnormal_neuron_morphology | 1.22029588 |
| 96 | MP0001986_abnormal_taste_sensitivity | 1.21531453 |
| 97 | MP0010155_abnormal_intestine_physiology | 1.21117360 |
| 98 | MP0000685_abnormal_immune_system | 1.18037075 |
| 99 | MP0003329_amyloid_beta_deposits | 1.17132742 |
| 100 | MP0001800_abnormal_humoral_immune | 1.16771356 |
| 101 | MP0005165_increased_susceptibility_to | 1.16564486 |
| 102 | MP0002254_reproductive_system_inflammat | 1.15449586 |
| 103 | MP0000858_altered_metastatic_potential | 1.15131337 |
| 104 | MP0000013_abnormal_adipose_tissue | 1.15008009 |
| 105 | MP0001819_abnormal_immune_cell | 1.13614308 |
| 106 | MP0002420_abnormal_adaptive_immunity | 1.13462266 |
| 107 | MP0003631_nervous_system_phenotype | 1.11969240 |
| 108 | MP0008877_abnormal_DNA_methylation | 1.09354921 |
| 109 | MP0002090_abnormal_vision | 1.06788973 |
| 110 | MP0010352_gastrointestinal_tract_polyps | 1.05887861 |
| 111 | MP0005164_abnormal_response_to | 1.04852504 |
| 112 | MP0008874_decreased_physiological_sensi | 1.04049332 |
| 113 | MP0001177_atelectasis | 1.03770014 |
| 114 | MP0003634_abnormal_glial_cell | 1.02993050 |
| 115 | MP0003828_pulmonary_edema | 1.02866917 |
| 116 | MP0001963_abnormal_hearing_physiology | 1.01056094 |
| 117 | MP0002405_respiratory_system_inflammati | 1.00811386 |
| 118 | MP0000516_abnormal_urinary_system | 0.99401714 |
| 119 | MP0005367_renal/urinary_system_phenotyp | 0.99401714 |
| 120 | MP0003091_abnormal_cell_migration | 0.97902225 |
| 121 | MP0001851_eye_inflammation | 0.97805262 |
| 122 | MP0003221_abnormal_cardiomyocyte_apopto | 0.97698048 |
| 123 | MP0008260_abnormal_autophagy | 0.93639606 |
| 124 | MP0003690_abnormal_glial_cell | 0.92051818 |
| 125 | MP0000569_abnormal_digit_pigmentation | 0.89462988 |
| 126 | MP0004233_abnormal_muscle_weight | 0.88330447 |
| 127 | MP0000681_abnormal_thyroid_gland | 0.87736246 |
| 128 | MP0005535_abnormal_body_temperature | 0.87454408 |
| 129 | MP0001542_abnormal_bone_strength | 0.87045372 |
| 130 | MP0002229_neurodegeneration | 0.87003797 |
| 131 | MP0004484_altered_response_of | 0.86058779 |
| 132 | MP0000920_abnormal_myelination | 0.86008829 |
| 133 | MP0009763_increased_sensitivity_to | 0.85078449 |
| 134 | MP0004742_abnormal_vestibular_system | 0.84611990 |
| 135 | MP0001191_abnormal_skin_condition | 0.84190811 |
| 136 | MP0002069_abnormal_eating/drinking_beha | 0.84019643 |
| 137 | MP0003632_abnormal_nervous_system | 0.83325464 |
| 138 | MP0009333_abnormal_splenocyte_physiolog | 0.82989032 |
| 139 | MP0004858_abnormal_nervous_system | 0.80996760 |
| 140 | MP0002152_abnormal_brain_morphology | 0.79654261 |
| 141 | MP0004885_abnormal_endolymph | 0.79549497 |
| 142 | MP0000015_abnormal_ear_pigmentation | 0.78955553 |
| 143 | MP0000465_gastrointestinal_hemorrhage | 0.78051005 |
| 144 | MP0000372_irregular_coat_pigmentation | 0.78021186 |
| 145 | MP0002796_impaired_skin_barrier | 0.77766406 |
| 146 | MP0000371_diluted_coat_color | 0.77670474 |
| 147 | MP0000631_abnormal_neuroendocrine_gland | 0.76276583 |
| 148 | MP0002837_dystrophic_cardiac_calcinosis | 0.75169216 |
| 149 | MP0001216_abnormal_epidermal_layer | 0.74305367 |
| 150 | MP0000716_abnormal_immune_system | 0.73190378 |
| 151 | MP0009278_abnormal_bone_marrow | 0.71924364 |
| 152 | MP0003075_altered_response_to | 0.71211462 |
| 153 | MP0003186_abnormal_redox_activity | 0.70473073 |
| 154 | MP0010678_abnormal_skin_adnexa | 0.70159358 |
| 155 | MP0000604_amyloidosis | 0.69548759 |
| 156 | MP0004147_increased_porphyrin_level | 0.68880598 |
| 157 | MP0004043_abnormal_pH_regulation | 0.68225963 |
| 158 | MP0008995_early_reproductive_senescence | 0.66958192 |
| 159 | MP0003950_abnormal_plasma_membrane | 0.66948047 |
| 160 | MP0002653_abnormal_ependyma_morphology | 0.66521728 |
| 161 | MP0004145_abnormal_muscle_electrophysio | 0.65942152 |
| 162 | MP0009765_abnormal_xenobiotic_induced | 0.64471267 |
| 163 | MP0003121_genomic_imprinting | 0.63678200 |
| 164 | MP0004883_abnormal_blood_vessel | 0.62863031 |
| 165 | MP0005388_respiratory_system_phenotype | 0.62769032 |
| 166 | MP0002133_abnormal_respiratory_system | 0.62769032 |
| 167 | MP0004808_abnormal_hematopoietic_stem | 0.62678188 |
| 168 | MP0005310_abnormal_salivary_gland | 0.61836002 |
| 169 | MP0003279_aneurysm | 0.59881223 |
| 170 | MP0000249_abnormal_blood_vessel | 0.59726387 |
| 171 | MP0001943_abnormal_respiration | 0.59284497 |
| 172 | MP0002398_abnormal_bone_marrow | 0.58248840 |
| 173 | MP0002332_abnormal_exercise_endurance | 0.53984140 |
| 174 | MP0000026_abnormal_inner_ear | 0.53835716 |
| 175 | MP0002009_preneoplasia | 0.53574027 |
| 176 | MP0000751_myopathy | 0.53300794 |
| 177 | MP0009697_abnormal_copulation | 0.52962912 |
| 178 | MP0005499_abnormal_olfactory_system | 0.51827877 |
| 179 | MP0005394_taste/olfaction_phenotype | 0.51827877 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.91178215 |
| 2 | Atonic seizures (HP:0010819) | 5.77169378 |
| 3 | Epileptic encephalopathy (HP:0200134) | 5.45514931 |
| 4 | Febrile seizures (HP:0002373) | 4.96066711 |
| 5 | Loss of speech (HP:0002371) | 4.32546255 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 4.24537840 |
| 7 | Disinhibition (HP:0000734) | 4.22032939 |
| 8 | Neurofibrillary tangles (HP:0002185) | 4.15079777 |
| 9 | Hyperventilation (HP:0002883) | 4.07824629 |
| 10 | Pheochromocytoma (HP:0002666) | 4.06710131 |
| 11 | Focal seizures (HP:0007359) | 4.05642856 |
| 12 | Absence seizures (HP:0002121) | 3.97902923 |
| 13 | Neuroendocrine neoplasm (HP:0100634) | 3.87418126 |
| 14 | Dialeptic seizures (HP:0011146) | 3.76844153 |
| 15 | Visual hallucinations (HP:0002367) | 3.72202324 |
| 16 | Apathy (HP:0000741) | 3.63932225 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.60249086 |
| 18 | Diminished motivation (HP:0000745) | 3.57198452 |
| 19 | Myokymia (HP:0002411) | 3.55285768 |
| 20 | Abnormal hair whorl (HP:0010721) | 3.36017777 |
| 21 | Fetal akinesia sequence (HP:0001989) | 3.33853099 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 3.31486317 |
| 23 | Cerebral inclusion bodies (HP:0100314) | 3.27738965 |
| 24 | Gait imbalance (HP:0002141) | 3.18007028 |
| 25 | Medial flaring of the eyebrow (HP:0010747) | 3.17275335 |
| 26 | Abnormal eating behavior (HP:0100738) | 3.13850763 |
| 27 | Failure to thrive in infancy (HP:0001531) | 3.10070951 |
| 28 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.05576448 |
| 29 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.05576448 |
| 30 | Broad-based gait (HP:0002136) | 3.04418564 |
| 31 | Nuclear cataract (HP:0100018) | 3.01926582 |
| 32 | Neuronal loss in central nervous system (HP:0002529) | 3.00644718 |
| 33 | Congenital primary aphakia (HP:0007707) | 3.00322860 |
| 34 | Tetraparesis (HP:0002273) | 2.93894122 |
| 35 | Recurrent bacterial skin infections (HP:0005406) | 2.92730733 |
| 36 | Systemic lupus erythematosus (HP:0002725) | 2.87185882 |
| 37 | Nephrogenic diabetes insipidus (HP:0009806) | 2.85155359 |
| 38 | Axonal loss (HP:0003447) | 2.80984808 |
| 39 | Progressive cerebellar ataxia (HP:0002073) | 2.75763365 |
| 40 | Polyphagia (HP:0002591) | 2.66899020 |
| 41 | Stomatitis (HP:0010280) | 2.58672497 |
| 42 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.58671830 |
| 43 | Poor coordination (HP:0002370) | 2.56281547 |
| 44 | Progressive neurologic deterioration (HP:0002344) | 2.55807159 |
| 45 | Recurrent abscess formation (HP:0002722) | 2.55015654 |
| 46 | Poor suck (HP:0002033) | 2.54954008 |
| 47 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.50392994 |
| 48 | Clumsiness (HP:0002312) | 2.49619810 |
| 49 | Akinesia (HP:0002304) | 2.49134509 |
| 50 | Autoimmune thrombocytopenia (HP:0001973) | 2.47965955 |
| 51 | Eczematoid dermatitis (HP:0000976) | 2.45598635 |
| 52 | Optic neuritis (HP:0100653) | 2.40131004 |
| 53 | Retrobulbar optic neuritis (HP:0100654) | 2.40131004 |
| 54 | Gaze-evoked nystagmus (HP:0000640) | 2.39175678 |
| 55 | Protruding tongue (HP:0010808) | 2.38068699 |
| 56 | Epileptiform EEG discharges (HP:0011182) | 2.37997915 |
| 57 | Interstitial pulmonary disease (HP:0006530) | 2.35538006 |
| 58 | Dysautonomia (HP:0002459) | 2.34571451 |
| 59 | Orchitis (HP:0100796) | 2.33358253 |
| 60 | Poor eye contact (HP:0000817) | 2.33308773 |
| 61 | Genital tract atresia (HP:0001827) | 2.30861253 |
| 62 | Personality changes (HP:0000751) | 2.29900065 |
| 63 | Vaginal atresia (HP:0000148) | 2.28780957 |
| 64 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.25710829 |
| 65 | Amblyopia (HP:0000646) | 2.24861290 |
| 66 | Increased CSF protein (HP:0002922) | 2.22777090 |
| 67 | Increased cerebral lipofuscin (HP:0011813) | 2.22452385 |
| 68 | Sleep apnea (HP:0010535) | 2.21921021 |
| 69 | Hematochezia (HP:0002573) | 2.20506232 |
| 70 | Agnosia (HP:0010524) | 2.20138532 |
| 71 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.19062678 |
| 72 | Drooling (HP:0002307) | 2.19024203 |
| 73 | Excessive salivation (HP:0003781) | 2.19024203 |
| 74 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.17625308 |
| 75 | Delusions (HP:0000746) | 2.17029426 |
| 76 | Petechiae (HP:0000967) | 2.16407008 |
| 77 | Abnormality of binocular vision (HP:0011514) | 2.15941703 |
| 78 | Diplopia (HP:0000651) | 2.15941703 |
| 79 | Termporal pattern (HP:0011008) | 2.14894059 |
| 80 | Insidious onset (HP:0003587) | 2.14894059 |
| 81 | Acute necrotizing encephalopathy (HP:0006965) | 2.14019235 |
| 82 | Dysdiadochokinesis (HP:0002075) | 2.13593049 |
| 83 | Hepatosplenomegaly (HP:0001433) | 2.12870275 |
| 84 | Abnormality of the labia minora (HP:0012880) | 2.12749577 |
| 85 | Specific learning disability (HP:0001328) | 2.12393476 |
| 86 | Amyloidosis (HP:0011034) | 2.11785736 |
| 87 | Prolonged neonatal jaundice (HP:0006579) | 2.11438632 |
| 88 | Myocardial infarction (HP:0001658) | 2.11258365 |
| 89 | EEG with generalized epileptiform discharges (HP:0011198) | 2.10512974 |
| 90 | Dementia (HP:0000726) | 2.09128795 |
| 91 | Diminished movement (HP:0002374) | 2.07393500 |
| 92 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.06713721 |
| 93 | Papilledema (HP:0001085) | 2.06389490 |
| 94 | Action tremor (HP:0002345) | 2.05580361 |
| 95 | Supranuclear gaze palsy (HP:0000605) | 2.04208328 |
| 96 | Purpura (HP:0000979) | 2.03532903 |
| 97 | Resting tremor (HP:0002322) | 2.02588458 |
| 98 | Impaired social interactions (HP:0000735) | 2.02422434 |
| 99 | Abnormal social behavior (HP:0012433) | 2.02422434 |
| 100 | Esotropia (HP:0000565) | 2.01699677 |
| 101 | Progressive macrocephaly (HP:0004481) | 2.01095977 |
| 102 | Anxiety (HP:0000739) | 2.00919526 |
| 103 | Truncal ataxia (HP:0002078) | 2.00117134 |
| 104 | Dysostosis multiplex (HP:0000943) | 1.99884435 |
| 105 | Myositis (HP:0100614) | 1.99539148 |
| 106 | Global brain atrophy (HP:0002283) | 1.99093919 |
| 107 | Asymmetric septal hypertrophy (HP:0001670) | 1.98615486 |
| 108 | Generalized myoclonic seizures (HP:0002123) | 1.98146543 |
| 109 | Mediastinal lymphadenopathy (HP:0100721) | 1.97840742 |
| 110 | Hypsarrhythmia (HP:0002521) | 1.95112517 |
| 111 | Papillary thyroid carcinoma (HP:0002895) | 1.95000937 |
| 112 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.94793646 |
| 113 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.94793646 |
| 114 | Upper motor neuron abnormality (HP:0002127) | 1.94766843 |
| 115 | Memory impairment (HP:0002354) | 1.92875010 |
| 116 | Sensorimotor neuropathy (HP:0007141) | 1.92476323 |
| 117 | Progressive inability to walk (HP:0002505) | 1.90664023 |
| 118 | Ankle clonus (HP:0011448) | 1.90105863 |
| 119 | Inability to walk (HP:0002540) | 1.90032677 |
| 120 | Increased serum ferritin (HP:0003281) | 1.88292622 |
| 121 | Blue irides (HP:0000635) | 1.88000687 |
| 122 | Hypothermia (HP:0002045) | 1.87717895 |
| 123 | Urinary incontinence (HP:0000020) | 1.87020351 |
| 124 | Basal ganglia calcification (HP:0002135) | 1.86950136 |
| 125 | Tongue fasciculations (HP:0001308) | 1.86943415 |
| 126 | Depression (HP:0000716) | 1.86932542 |
| 127 | Gangrene (HP:0100758) | 1.86578413 |
| 128 | Polyneuropathy (HP:0001271) | 1.86207881 |
| 129 | Oligomenorrhea (HP:0000876) | 1.84649658 |
| 130 | Cerebral hemorrhage (HP:0001342) | 1.84643864 |
| 131 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.84388338 |
| 132 | Dysmetria (HP:0001310) | 1.83623366 |
| 133 | Thick nail (HP:0001805) | 1.83178701 |
| 134 | Narrow nasal bridge (HP:0000446) | 1.82090191 |
| 135 | Autoimmune hemolytic anemia (HP:0001890) | 1.81641163 |
| 136 | Pulmonary infiltrates (HP:0002113) | 1.80961724 |
| 137 | Absent speech (HP:0001344) | 1.80732465 |
| 138 | Postural tremor (HP:0002174) | 1.79484271 |
| 139 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.79366053 |
| 140 | Mucopolysacchariduria (HP:0008155) | 1.79366053 |
| 141 | Mutism (HP:0002300) | 1.78582157 |
| 142 | Abnormality of the periventricular white matter (HP:0002518) | 1.78186640 |
| 143 | Hypokinesia (HP:0002375) | 1.77775588 |
| 144 | Abnormality of glycolipid metabolism (HP:0010969) | 1.74852303 |
| 145 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.74852303 |
| 146 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.74852303 |
| 147 | Bradykinesia (HP:0002067) | 1.73924609 |
| 148 | Thickened helices (HP:0000391) | 1.73690483 |
| 149 | Vertebral compression fractures (HP:0002953) | 1.73636763 |
| 150 | Abnormality of the basal ganglia (HP:0002134) | 1.73191821 |
| 151 | Inappropriate behavior (HP:0000719) | 1.72691327 |
| 152 | Hip dysplasia (HP:0001385) | 1.70501319 |
| 153 | Absent eyebrow (HP:0002223) | 1.68921312 |
| 154 | Joint swelling (HP:0001386) | 1.68693360 |
| 155 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.68392855 |
| 156 | Episodic fever (HP:0001954) | 1.68070533 |
| 157 | Mitochondrial inheritance (HP:0001427) | 1.67894557 |
| 158 | Slow saccadic eye movements (HP:0000514) | 1.67478913 |
| 159 | Keratoconjunctivitis sicca (HP:0001097) | 1.65270288 |
| 160 | Glomerulonephritis (HP:0000099) | 1.65077641 |
| 161 | Abnormality of the corticospinal tract (HP:0002492) | 1.64110767 |
| 162 | Autoamputation (HP:0001218) | 1.63546280 |
| 163 | Tetraplegia (HP:0002445) | 1.63178091 |
| 164 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.63076554 |
| 165 | Postural instability (HP:0002172) | 1.62364537 |
| 166 | Abnormality of salivation (HP:0100755) | 1.61649739 |
| 167 | Increased serum pyruvate (HP:0003542) | 1.61455158 |
| 168 | Abnormality of glycolysis (HP:0004366) | 1.61455158 |
| 169 | Submucous cleft hard palate (HP:0000176) | 1.61264480 |
| 170 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.61254075 |
| 171 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.61045553 |
| 172 | Cardiomegaly (HP:0001640) | 1.61045472 |
| 173 | Parakeratosis (HP:0001036) | 1.58778957 |
| 174 | Spastic gait (HP:0002064) | 1.58199789 |
| 175 | Conjunctival hamartoma (HP:0100780) | 1.57957732 |
| 176 | Nausea (HP:0002018) | 1.56485893 |
| 177 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.54956653 |
| 178 | Rapidly progressive (HP:0003678) | 1.54852003 |
| 179 | Bone pain (HP:0002653) | 1.54321008 |
| 180 | Conjunctival telangiectasia (HP:0000524) | 1.53287238 |
| 181 | Cholecystitis (HP:0001082) | 1.52449746 |
| 182 | Abnormal gallbladder physiology (HP:0012438) | 1.52449746 |
| 183 | Albinism (HP:0001022) | 1.52156282 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.29812389 |
| 2 | IRAK3 | 5.10171865 |
| 3 | AKT3 | 3.10931808 |
| 4 | NTRK3 | 2.97336318 |
| 5 | MAP2K7 | 2.92189667 |
| 6 | MAP3K12 | 2.89045915 |
| 7 | PRPF4B | 2.75375830 |
| 8 | PLK2 | 2.70325010 |
| 9 | EPHA4 | 2.65860681 |
| 10 | MAP3K4 | 2.46818363 |
| 11 | RIPK4 | 2.30242566 |
| 12 | DAPK1 | 2.28126254 |
| 13 | GRK7 | 2.23914938 |
| 14 | SIK3 | 2.23499877 |
| 15 | NME2 | 2.10059648 |
| 16 | TBK1 | 2.02742271 |
| 17 | MINK1 | 1.89394067 |
| 18 | CCNB1 | 1.83995174 |
| 19 | CDK19 | 1.83270759 |
| 20 | MAP3K13 | 1.73084964 |
| 21 | DAPK2 | 1.72322823 |
| 22 | SGK2 | 1.70896081 |
| 23 | ERBB3 | 1.67627462 |
| 24 | RIPK1 | 1.62733652 |
| 25 | MOS | 1.55632782 |
| 26 | BMPR2 | 1.55294989 |
| 27 | LATS2 | 1.49407441 |
| 28 | IKBKB | 1.45399073 |
| 29 | SCYL2 | 1.44819633 |
| 30 | SGK494 | 1.44041379 |
| 31 | SGK223 | 1.44041379 |
| 32 | TGFBR2 | 1.42933049 |
| 33 | TESK1 | 1.36424950 |
| 34 | TYK2 | 1.36276499 |
| 35 | PINK1 | 1.34406601 |
| 36 | CAMKK2 | 1.34386628 |
| 37 | EIF2AK3 | 1.33687585 |
| 38 | MAPK13 | 1.32140400 |
| 39 | MAP3K5 | 1.31448778 |
| 40 | MAP2K4 | 1.31309595 |
| 41 | MAP3K1 | 1.30919842 |
| 42 | OXSR1 | 1.29127909 |
| 43 | MAP3K6 | 1.24238093 |
| 44 | MAP3K9 | 1.21534542 |
| 45 | BLK | 1.20606581 |
| 46 | JAK1 | 1.19727864 |
| 47 | UHMK1 | 1.16729285 |
| 48 | SGK3 | 1.16647140 |
| 49 | TSSK6 | 1.15855718 |
| 50 | EPHA3 | 1.14257405 |
| 51 | MARK1 | 1.13726557 |
| 52 | PDK3 | 1.12563679 |
| 53 | PDK4 | 1.12563679 |
| 54 | ABL2 | 1.12282883 |
| 55 | FRK | 1.11684220 |
| 56 | TRIM28 | 1.11048188 |
| 57 | IKBKE | 1.10338788 |
| 58 | YES1 | 1.10168432 |
| 59 | PRKCG | 1.09308764 |
| 60 | BCR | 1.05643034 |
| 61 | GRK5 | 1.04784236 |
| 62 | CDK5 | 1.00764270 |
| 63 | IRAK2 | 0.98031295 |
| 64 | BMPR1B | 0.97258612 |
| 65 | NEK6 | 0.97229594 |
| 66 | MST4 | 0.97004341 |
| 67 | CAMK2A | 0.96126324 |
| 68 | ARAF | 0.94475957 |
| 69 | JAK2 | 0.93866302 |
| 70 | CAMK2B | 0.92868721 |
| 71 | MAP3K2 | 0.90945425 |
| 72 | TNIK | 0.90758187 |
| 73 | PRKCE | 0.90222975 |
| 74 | PDK2 | 0.87990330 |
| 75 | CSK | 0.87487638 |
| 76 | MAPK15 | 0.87351181 |
| 77 | MKNK2 | 0.87240968 |
| 78 | TAOK1 | 0.86561611 |
| 79 | MAP2K3 | 0.86202966 |
| 80 | PAK6 | 0.86048540 |
| 81 | PRKD3 | 0.85693547 |
| 82 | CDK6 | 0.85601573 |
| 83 | DDR2 | 0.84740893 |
| 84 | KSR1 | 0.82926040 |
| 85 | FGR | 0.82486612 |
| 86 | NME1 | 0.82389762 |
| 87 | JAK3 | 0.81154266 |
| 88 | BRAF | 0.80865020 |
| 89 | CDK8 | 0.80212586 |
| 90 | TAOK3 | 0.79556212 |
| 91 | CAMKK1 | 0.75434331 |
| 92 | BRSK1 | 0.71708494 |
| 93 | NTRK2 | 0.71523532 |
| 94 | PDGFRA | 0.71253399 |
| 95 | TAOK2 | 0.68198685 |
| 96 | ADRBK2 | 0.66802884 |
| 97 | NTRK1 | 0.65922871 |
| 98 | CDK18 | 0.64917387 |
| 99 | ACVR1B | 0.63215497 |
| 100 | ZAP70 | 0.63109516 |
| 101 | SGK1 | 0.62285173 |
| 102 | CDK14 | 0.59621596 |
| 103 | SYK | 0.58504925 |
| 104 | CHUK | 0.57755923 |
| 105 | MATK | 0.57277096 |
| 106 | IRAK1 | 0.56845390 |
| 107 | CLK1 | 0.56833866 |
| 108 | PLK3 | 0.55906828 |
| 109 | MARK3 | 0.55304191 |
| 110 | FES | 0.55265483 |
| 111 | STK24 | 0.54349165 |
| 112 | PKN1 | 0.52911023 |
| 113 | MAPK4 | 0.52315335 |
| 114 | MAP3K11 | 0.51685670 |
| 115 | CAMK2D | 0.51478975 |
| 116 | TXK | 0.50866616 |
| 117 | CDK15 | 0.50197419 |
| 118 | NEK9 | 0.49953229 |
| 119 | RPS6KA2 | 0.49003383 |
| 120 | PHKG2 | 0.48465134 |
| 121 | PHKG1 | 0.48465134 |
| 122 | IRAK4 | 0.47457328 |
| 123 | NEK1 | 0.46817767 |
| 124 | DAPK3 | 0.46756750 |
| 125 | PIM2 | 0.46456638 |
| 126 | ABL1 | 0.46322006 |
| 127 | PAK4 | 0.44989413 |
| 128 | RPS6KL1 | 0.44855680 |
| 129 | RPS6KC1 | 0.44855680 |
| 130 | LYN | 0.44517491 |
| 131 | CAMK2G | 0.44455226 |
| 132 | EIF2AK1 | 0.44440495 |
| 133 | TRPM7 | 0.44096236 |
| 134 | MAP3K3 | 0.43758864 |
| 135 | MAP2K6 | 0.43232698 |
| 136 | RPS6KB1 | 0.43220818 |
| 137 | ALK | 0.42394397 |
| 138 | LIMK1 | 0.39949053 |
| 139 | FER | 0.39503183 |
| 140 | PRKCH | 0.38505941 |
| 141 | DYRK1A | 0.38418997 |
| 142 | FGFR3 | 0.38315100 |
| 143 | RAF1 | 0.37609255 |
| 144 | RPS6KA6 | 0.37334100 |
| 145 | TYRO3 | 0.35784201 |
| 146 | PDPK1 | 0.35279988 |
| 147 | MKNK1 | 0.35085171 |
| 148 | CDK11A | 0.34997251 |
| 149 | MAP2K1 | 0.34744912 |
| 150 | HCK | 0.34482964 |
| 151 | PDK1 | 0.34429610 |
| 152 | KSR2 | 0.34003732 |
| 153 | GSK3A | 0.33604937 |
| 154 | MAP3K14 | 0.33500685 |
| 155 | TEC | 0.33061256 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.25167923 |
| 2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.82613952 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.55722465 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.85261870 |
| 5 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.69965717 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.61619580 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.52063028 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.40909438 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.36067586 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.28758036 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.28605532 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.21253585 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.21176069 |
| 14 | Morphine addiction_Homo sapiens_hsa05032 | 2.20037547 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.08639043 |
| 16 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 2.02723457 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.96259722 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.95795899 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.94940235 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.92326894 |
| 21 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.84530816 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.83361294 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.77558964 |
| 24 | Phagosome_Homo sapiens_hsa04145 | 1.74645779 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.74638146 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.73648470 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.72923623 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.71417310 |
| 29 | Long-term depression_Homo sapiens_hsa04730 | 1.66397500 |
| 30 | Insulin secretion_Homo sapiens_hsa04911 | 1.64147598 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.58840541 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.56775220 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.54583879 |
| 34 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.52468693 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.48807101 |
| 36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.47016942 |
| 37 | Salivary secretion_Homo sapiens_hsa04970 | 1.45280916 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.44071548 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.43661775 |
| 40 | Asthma_Homo sapiens_hsa05310 | 1.42798400 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.41971967 |
| 42 | Renin secretion_Homo sapiens_hsa04924 | 1.35334056 |
| 43 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.35274013 |
| 44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.34832016 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.29245700 |
| 46 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.27708270 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 1.27535950 |
| 48 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.27023163 |
| 49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.25730235 |
| 50 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.25329178 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.22651365 |
| 52 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.21539387 |
| 53 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.21029102 |
| 54 | Cocaine addiction_Homo sapiens_hsa05030 | 1.13947670 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 1.12792626 |
| 56 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12752632 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.10164883 |
| 58 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.07266410 |
| 59 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.06786328 |
| 60 | Gap junction_Homo sapiens_hsa04540 | 1.06245929 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 1.04580810 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 1.01649582 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.97632397 |
| 64 | Measles_Homo sapiens_hsa05162 | 0.96684154 |
| 65 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.95366669 |
| 66 | Hepatitis B_Homo sapiens_hsa05161 | 0.94486872 |
| 67 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92499477 |
| 68 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92194833 |
| 69 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.92106421 |
| 70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.91981284 |
| 71 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.91755249 |
| 72 | Alzheimers disease_Homo sapiens_hsa05010 | 0.91722809 |
| 73 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.89640710 |
| 74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.88280622 |
| 75 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88090861 |
| 76 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.87885059 |
| 77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87371084 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.87204099 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.87114581 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87034044 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87024776 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.84639140 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83767257 |
| 84 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.81337547 |
| 85 | Axon guidance_Homo sapiens_hsa04360 | 0.80705878 |
| 86 | Protein export_Homo sapiens_hsa03060 | 0.78047099 |
| 87 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.77815567 |
| 88 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.77575465 |
| 89 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.77368025 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77125230 |
| 91 | Parkinsons disease_Homo sapiens_hsa05012 | 0.76679361 |
| 92 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75260558 |
| 93 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.73267602 |
| 94 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.71460474 |
| 95 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71387695 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69050286 |
| 97 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65102472 |
| 98 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.64606982 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63622926 |
| 100 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.63590752 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62970600 |
| 102 | Tuberculosis_Homo sapiens_hsa05152 | 0.62810816 |
| 103 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61950592 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61834005 |
| 105 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61547029 |
| 106 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61022040 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.60252419 |
| 108 | Huntingtons disease_Homo sapiens_hsa05016 | 0.59968504 |
| 109 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.58757311 |
| 110 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.58637991 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.57728419 |
| 112 | Platelet activation_Homo sapiens_hsa04611 | 0.57616285 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56909560 |
| 114 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.56834535 |
| 115 | Legionellosis_Homo sapiens_hsa05134 | 0.56454084 |
| 116 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56314227 |
| 117 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55142563 |
| 118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.54979765 |
| 119 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54170620 |
| 120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53269789 |
| 121 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51868937 |
| 122 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50096065 |
| 123 | Melanogenesis_Homo sapiens_hsa04916 | 0.49639642 |
| 124 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48594591 |
| 125 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47868195 |
| 126 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47860161 |
| 127 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.46532762 |
| 128 | Salmonella infection_Homo sapiens_hsa05132 | 0.44748657 |
| 129 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.44477663 |
| 130 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43291525 |
| 131 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39499678 |
| 132 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39374039 |
| 133 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.38216929 |
| 134 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37340492 |
| 135 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.36044094 |
| 136 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35653577 |
| 137 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35624775 |
| 138 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.35232461 |
| 139 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34696095 |
| 140 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34689459 |
| 141 | Endocytosis_Homo sapiens_hsa04144 | 0.34058497 |
| 142 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31865225 |
| 143 | Phototransduction_Homo sapiens_hsa04744 | 0.31076241 |
| 144 | Melanoma_Homo sapiens_hsa05218 | 0.30894914 |
| 145 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30259220 |
| 146 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.30154964 |
| 147 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.30003021 |
| 148 | Mineral absorption_Homo sapiens_hsa04978 | 0.29569863 |
| 149 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.29167064 |
| 150 | Shigellosis_Homo sapiens_hsa05131 | 0.28786550 |
| 151 | Prion diseases_Homo sapiens_hsa05020 | 0.28336159 |
| 152 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.26993945 |
| 153 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.24050502 |
| 154 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23650932 |
| 155 | Proteasome_Homo sapiens_hsa03050 | 0.22593867 |
| 156 | Endometrial cancer_Homo sapiens_hsa05213 | 0.19475547 |
| 157 | Pertussis_Homo sapiens_hsa05133 | 0.19372045 |
| 158 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19042740 |

